Amgen Statistics
Total Valuation
Amgen has a market cap or net worth of CAD 358.98 billion. The enterprise value is 417.15 billion.
| Market Cap | 358.98B |
| Enterprise Value | 417.15B |
Important Dates
The last earnings date was Tuesday, November 3, 2026.
| Earnings Date | Nov 3, 2026 |
| Ex-Dividend Date | Nov 20, 2026 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.46% |
| Shares Change (QoQ) | +0.37% |
| Owned by Insiders (%) | 0.17% |
| Owned by Institutions (%) | 83.78% |
| Float | 539.44M |
Valuation Ratios
The trailing PE ratio is 38.94 and the forward PE ratio is 19.17.
| PE Ratio | 38.94 |
| Forward PE | 19.17 |
| PS Ratio | 6.50 |
| PB Ratio | 17.62 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 26.39 |
| P/OCF Ratio | 21.01 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 16.36, with an EV/FCF ratio of 30.67.
| EV / Earnings | 31.29 |
| EV / Sales | 7.52 |
| EV / EBITDA | 16.36 |
| EV / EBIT | 22.05 |
| EV / FCF | 30.67 |
Financial Position
The company has a current ratio of 1.48, with a Debt / Equity ratio of 3.76.
| Current Ratio | 1.48 |
| Quick Ratio | 1.01 |
| Debt / Equity | 3.76 |
| Debt / EBITDA | 3.02 |
| Debt / FCF | 5.64 |
| Interest Coverage | 4.36 |
Financial Efficiency
Return on equity (ROE) is 78.35% and return on invested capital (ROIC) is 20.48%.
| Return on Equity (ROE) | 78.35% |
| Return on Assets (ROA) | 8.91% |
| Return on Invested Capital (ROIC) | 20.48% |
| Return on Capital Employed (ROCE) | 18.23% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 1.75M |
| Profits Per Employee | 423,236 |
| Employee Count | 31,500 |
| Asset Turnover | 0.42 |
| Inventory Turnover | 1.68 |
Taxes
In the past 12 months, Amgen has paid 2.36 billion in taxes.
| Income Tax | 2.36B |
| Effective Tax Rate | 15.03% |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 31.49 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 61.11 |
| Average Volume (20 Days) | 3,359 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 4.49 |
Income Statement
In the last 12 months, Amgen had revenue of CAD 55.23 billion and earned 13.33 billion in profits. Earnings per share was 0.88.
| Revenue | 55.23B |
| Gross Profit | 40.02B |
| Operating Income | 18.84B |
| Pretax Income | 15.69B |
| Net Income | 13.33B |
| EBITDA | 25.03B |
| EBIT | 18.84B |
| Earnings Per Share (EPS) | 0.88 |
Balance Sheet
The company has 18.73 billion in cash and 76.67 billion in debt, with a net cash position of -57.95 billion.
| Cash & Cash Equivalents | 18.73B |
| Total Debt | 76.67B |
| Net Cash | -57.95B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 20.37B |
| Book Value Per Share | 1.35 |
| Working Capital | 15.80B |
Cash Flow
In the last 12 months, operating cash flow was 17.09 billion and capital expenditures -3.48 billion, giving a free cash flow of 13.60 billion.
| Operating Cash Flow | 17.09B |
| Capital Expenditures | -3.48B |
| Depreciation & Amortization | 6.22B |
| Net Borrowing | -216.97M |
| Free Cash Flow | 13.60B |
| FCF Per Share | n/a |
Margins
Gross margin is 72.46%, with operating and profit margins of 34.12% and 24.14%.
| Gross Margin | 72.46% |
| Operating Margin | 34.12% |
| Pretax Margin | 28.41% |
| Profit Margin | 24.14% |
| EBITDA Margin | 45.32% |
| EBIT Margin | 34.12% |
| FCF Margin | 24.49% |
Dividends & Yields
This stock pays an annual dividend of 0.75, which amounts to a dividend yield of 2.18%.
| Dividend Per Share | 0.75 |
| Dividend Yield | 2.18% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 57.14% |
| FCF Payout Ratio | n/a |
| Buyback Yield | -0.46% |
| Shareholder Yield | 1.72% |
| Earnings Yield | 2.57% |
| FCF Yield | 3.79% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Amgen has an Altman Z-Score of 2.11 and a Piotroski F-Score of 8. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.11 |
| Piotroski F-Score | 8 |